Streck scientists will discuss accelerated workflow analysis options and present a poster on a new versatile real-time PCR instrument at this years Molecular Medicine Tri-Conference in San Francisco.
Dr. Chris Connelly, Strecks R&D molecular technology scientific manager, will speak on Monday March 7, at 4:25 p.m. in the Molecular Diagnostics for Infectious Disease track. His presentation will focus on PCR-based applications for the Philisa® Real-Time PCR System that serve to accelerate workflow for molecular diagnostic analysis. Critical assays for infectious disease testing, such as detection of antibiotic resistant bacteria and RT-PCR-based identification of viruses, will benefit from the versatility and performance of the Philisa Real-Time PCR System.
Dr. Scott Whitney, Strecks R&D senior scientist, will present a poster which addresses engineering the Philisa Real-Time PCR System, a rapid and versatile real-time thermal cycler.
Visit Streck booth #508 and learn more about Strecks molecular and cell stabilization products.
About Molecular Medicine Tri-Conference
This event focuses on molecular medicine, specifically on discovery, genomics, diagnostics and information technology, and attracts over 3,300 professionals from more than 40 countries. For more information, visit www.triconference.com.
About Streck, Inc.
Streck is an industry leader in the development and manufacturing of products for clinical and research laboratories. The companys pursuit of innovative solutions has produced an extensive list of patented products. Strecks core technology is cell stabilization; product lines support the fields of hematology, immunology and molecular diagnostics. For more information, visit www.streck.com.